Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Insider Trading Spectrum: From Small-Scale Buddies To “Most Lucrative Inside Tip Of All Time”

Executive Summary

SEC was able to trace trading patterns and relationships between former high school friends back to employees at Celgene and Sanofi; SEC also filed a complaint against a former hedge fund manager who made a record $276 million profit trading on insider information about Alzheimer’s disease drug bapineuzumab.


Related Content

Pharma-Related Probes Could Be Impacted By Departure Of US Attorneys
Insider Trading: Pharma Employees Increasingly In SEC Crosshairs
Beyond Bapi: Alzheimer’s Pipeline Runs Deep
Insider Trading Bull's-Eye: FDA Chemist Charged With Using Agency's DARRTS NDA Tracking System For Improper Trades
Wyeth’s Pipeline Star Bapineuzumab Looks More Long Shot Than Sure Bet


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts